- Home
- Equipment
- usa new york
- clinical validation
Refine by
Clinical Validation Equipment Supplied In Usa New York
14 equipment items found
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
CT-132 is under development as a clinically-validated digital program for ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Clickadian is under development as a clinically-validated fully digital program for ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Clickheart is under development as a clinically-validated digital program for acute coronary ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
CT-161 is under development as a clinically-validated digital program for overactive ...
Manufactured by:Reichert, Inc based inDepew, NEW YORK (USA)
As such, IOPcc is a better indicator of glaucoma risk than other methods of tonometry, including Goldmann Applanation. The Reichert 7CR is more clinically valid in all subjects, including: normal tension glaucoma patients, primary open angle glaucoma patients, post-LASIK and refractive surgery patients, patients with Fuchs' or corneal edema, keratoconus patients, ...
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
Inhibition of XPO1 has been shown to restore tumor suppressor function and proper cell cycle regulation, leading to apoptosis of cancer cells. XPO1 has also been shown to be a clinically validated target in both solid and hematological cancers. SL-801 has demonstrated broad and SL-801 has demonstrated broad and potent preclinical activity in a wide array of solid ...
Manufactured by:Viora based in, NEW YORK (USA)
Transform Your Patients from Head-To-Toe! Now offer your patients a wide range of body and facial solutions, delivered by Viora’s powerful RF and fractional RF based technologies, for superior results. Viora’s V10 Multi-Technology platform – part of the V-Series – provides treatment solutions for the most requested ...
Manufactured by:Viora based in, NEW YORK (USA)
Want to meet your customers’ needs with advanced light and RF technology? Viora’s V20 Multi-Technology Platform delivers! Viora’s V20 Multi-Technology platform – part of the V-Series – provides treatment solutions for the most requested ...
Manufactured by:Viora based in, NEW YORK (USA)
Tired of purchasing numerous different devices to stay competitive and meet your customers demands? Still paying off your investment on already obsolete technology? Viora’s V30 Multi-Technology platform (part of the V-Series ) is specifically designed to meet these challenges and ...
Manufactured by:ZeptoMetrix - ANTYLIA Scientific based inBuffalo, NEW YORK (USA)
The Zika Antibody Control Pack consists of onevial each ofIgG, IgM and negative antibody controls. The IgG and IgM controls contain anti-Zika NS1 mouse monoclonal antibody conjugated to purified human IgG or IgM, respectively. All controls are supplied in normal human plasma, 0.09% sodium azide and other stabilizing reagents.These controls are designed to mimic actual Zika positive and negative ...
Manufactured by:UV Smart Technologies B.V. based inRijswijk, NETHERLANDS
Revolutionary solution based on UV-C ...
by:Geistlich Pharma North America Inc. based inPrinceton, NEW YORK (USA)
Patients’ medical and dental histories, or bone defect position are just a couple of factors that may add complexity to your dental regenerative procedures. In addition, patient’s demand for reduced treatment time, long-lasting and non-painful solutions is increasing. The Geistlich Bio-Oss Pen® is a pre-filled syringe containing Geistlich Bio-Oss® granules, the leading bone ...
Manufactured by:Carestream Health based inRochester, NEW YORK (USA)
Since its introduction, our flagship DRX-Evolution Plus has set a benchmark for X-ray room imaging performance. Today, it still offers modular design to fit your individual space, workflow and budget. But at Carestream, imaging innovation is not a goal – it’s an ongoing ...
Manufactured by:Scopus BioPharma based inNew York, NEW YORK (USA)
We are developing MRI-1867, our licensed rationally designed, orally available, dual-action, hybrid, small molecule that is an inverse agonist of the CB1 receptor, as well as an inhibitor of the iNOS ...
